Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 4,620 | 501 | 4,044 |
| Samples | 1,107 | 186 | 899 |
| Peptides | 854 | 133 | 748 |
Function
MYH11 · Myosin heavy chain 11
The protein encoded by this gene is a smooth muscle myosin belonging to the myosin heavy chain family. The gene product is a subunit of a hexameric protein that consists of two heavy chain subunits and two pairs of non-identical light chain subunits. It functions as a major contractile protein, converting chemical energy into mechanical energy through the hydrolysis of ATP. A chromosomal rearrangement involving this gene is associated with acute myeloid leukemia of the M4Eo subtype. Mutations in this gene are associated with visceral myopathy, megacystis-microcolon-intestinal hypoperistalsis syndrome 2, and familial thoracic aortic aneurysm 4. [provided by RefSeq, May 2022].
Isoforms & Proteins
6 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
Gene Properties
Recurrent Mutations
All 823 amino-acid changes on canonical ENST00000300036 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in MYH11 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in MYH11 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| T-Lymphoblastic Leukemia | 10/40 25% | 0/0 0% |
| Endometrial Carcinoma | 10/42 24% | 43/612 7% |
| Melanoma | 22/210 10% | 143/1899 8% |
| Unknown | 0/10 0% | 2/29 7% |
| Colorectal Carcinoma | 24/143 17% | 131/3239 4% |
| T-Cell Non-Hodgkins Lymphoma | 1/26 4% | 0/0 0% |
| Non-Small Cell Lung Carcinoma | 19/304 6% | 46/1390 3% |
| Other Solid Cancers | 5/94 5% | 56/1515 4% |
| Oral Cavity Carcinoma | 2/54 4% | 0/0 0% |
| Gastric Carcinoma | 7/74 9% | 62/1809 3% |
| Bladder Carcinoma | 1/58 2% | 34/956 4% |
| Cervical Carcinoma | 1/35 3% | 14/422 3% |
| Glioblastoma | 3/98 3% | 0/0 0% |
| Squamous Cell Lung Carcinoma | 5/57 9% | 21/810 3% |
| Other Sarcomas | 6/69 9% | 15/699 2% |
| Esophageal Carcinoma | 3/23 13% | 16/769 2% |
| Gastrointestinal Stromal Tumour | 0/0 0% | 3/133 2% |
| Ovarian Carcinoma | 4/109 4% | 20/998 2% |
| Non-Cancerous | 0/104 0% | 19/830 2% |
| Neuroendocrine Tumour | 10/154 6% | 4/577 1% |
| Mesothelioma | 4/62 6% | 0/165 0% |
| Retinoblastoma | 0/27 0% | 1/30 3% |
| Thyroid Gland Carcinoma | 1/45 2% | 27/1592 2% |
| Biliary Tract Carcinoma | 3/54 6% | 14/950 1% |
| Head and Neck Carcinoma | 1/85 1% | 26/1574 2% |
| Glioma | 2/52 4% | 32/2127 2% |
| Hodgkins Lymphoma | 0/16 0% | 2/122 2% |
| Esophageal Squamous Cell Carcinoma | 5/51 10% | 32/2550 1% |
| Ewings Sarcoma | 4/63 6% | 0/262 0% |
| Small Cell Lung Carcinoma | 0/9 0% | 9/752 1% |
Mutation Distribution
Where MYH11 is mutated · all tissues, split by cell line vs tissue
How many mutations in MYH11 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 54 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 4,620 mutations in MYH11
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|